{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:40:29Z","timestamp":1792813229857,"version":"4.5.0"},"reference-count":28,"publisher":"Massachusetts Medical Society","issue":"8","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100014487","name":"Clovis Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014487","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA008748"],"award-info":[{"award-number":["P30-CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2023,2,23]]},"DOI":"10.1056\/nejmoa2214676","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T10:45:15Z","timestamp":1676544315000},"page":"719-732","source":"Crossref","is-referenced-by-count":443,"title":["Rucaparib or Physician\u2019s Choice in Metastatic Prostate Cancer"],"prefix":"10.1056","volume":"388","author":[{"given":"Karim","family":"Fizazi","sequence":"first","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Piulats","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Neil","family":"Reaume","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ostler","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"McDermott","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel R.","family":"Gingerich","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Pintus","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikala S.","family":"Sridhar","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Bambury","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban","family":"Emmenegger","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Lindberg","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Morris","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Nol\u00e8","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Staffurth","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Redfern","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda I.","family":"S\u00e1ez","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Abida","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gedske","family":"Daugaard","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Heidenreich","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Krieger","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brieuc","family":"Sautois","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Loehr","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrin","family":"Despain","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Heyes","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8628-8399","authenticated-orcid":false,"given":"Simon P.","family":"Watkins","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Ryan","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0206-3895","authenticated-orcid":false,"given":"Alan H.","family":"Bryce","sequence":"additional","affiliation":[{"name":"From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Catal\u00e0 d\u2019Oncologia\u2013Bellvitge Institute for Biomedical Research \u2013CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga (M.I.S.) \u2014 both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook Health Sciences Centre (U.E.), Toronto \u2014 all in Canada; Mount Vernon Cancer Centre, Northwood (P.O.), Guy\u2019s Hospital (E.P.) and Guy\u2019s Hospital and Sarah Cannon Research Institute (S.C.), London, Velindre University NHS Trust, Cardiff (J.S.), and Clovis Oncology UK, Cambridge (C.A.H., S.P.W.) \u2014 all in the United Kingdom; St. Vincent\u2019s University Hospital and Cancer Trials Ireland, Dublin (R.M.), and Cork University Hospital, Wilton (R.M.B.) \u2014 both in Ireland; Herlev University Hospital, Herlev (H.L.), and Copenha..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.04.002"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.09.036"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/OP.21.00206"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03445"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03443"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.0812"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611310"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706450"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911440"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903387"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01035"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00376-4"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0394"},{"key":"e_1_3_5_15_2","volume-title":"Rubraca (rucaparib) tablets","year":"2022","unstructured":"Rubraca (rucaparib) tablets. Boulder, CO: Clovis Oncology, 2022 (package insert)."},{"key":"e_1_3_5_16_2","unstructured":"National Comprehensive Cancer Network. Prostate cancer version 1. Clinical practice guidelines in oncology (NCCN guidelines). 2023 (https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf)."},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.06.011"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2702"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02304"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.03.272"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-1008"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01600-6"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.1068"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-0886"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.6_suppl.011"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.5018"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200043"},{"key":"e_1_3_5_29_2","volume-title":"Lynparza (olaparib) tablets","year":"2022","unstructured":"Lynparza (olaparib) tablets. Wilmington, DE: AstraZeneca Pharmaceuticals, 2022 (package insert)."}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2214676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:59:43Z","timestamp":1749668383000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2214676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,2,23]]}},"alternative-id":["10.1056\/NEJMoa2214676"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2214676","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742535217.793598374","asserted-by":"object"}]},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]}}}